Regeneron Pharmaceuticals Inc Share Price
NASDAQ: REGNHealthcare
Live Regeneron Pharmaceuticals Inc Share Price Chart
O H L
Regeneron Pharmaceuticals Inc Performance Overview
Days Range
▼
$780.00Low
$793.56High
Markets Today
| Previous Close | $789.45 |
|---|---|
| Open | $793.56 |
| Volume | 2,263,893 |
| Day's Range | $780.00 - $793.56 |
| 52W Range | $541.00 - $859.34 |
| Market Cap | $79.75 B |
Historical Performance
| 1M Returns | -2.57 |
|---|---|
| 3M Returns | +29.43 |
| 6M Returns | +6.09 |
| 1Y Returns | +31.86 |
| 5Y Returns | +21.10 |
| 10Y Returns | +95.98 |
Regeneron Pharmaceuticals Inc Fundamentals
| Market Cap | $79.75 B |
|---|---|
| Dividend yield | 0.49 |
| PE Ratio | 18.96 |
| PEG Ratio | N/A |
| Revenue | $14.34 B |
| ROE TTM | 0.15 |
| EPS TTM | $40.86 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.53 |
| EBITDA | $4.11 B |
| Profit Margin | 31.41 |
| Market Cap | $79.75 B |
|---|---|
| Dividend yield | 0.49 |
| PE Ratio | 18.96 |
| PEG Ratio | N/A |
| Revenue | $14.34 B |
| ROE TTM | 0.15 |
| EPS TTM | $40.86 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.53 |
| EBITDA | $4.11 B |
| Profit Margin | 31.41 |
Regeneron Pharmaceuticals Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $3.03 B | $3.68 B | $3.75 B | $3.88 B | $3.61 B | $4.29 B |
| Gross Profit + | $2.56 B | $3.15 B | $3.23 B | $3.30 B | $2.94 B | $3.71 B |
| Operating Income | $591.70 M | $1.08 B | $1.03 B | $869.90 M | $642.90 M | $1.29 B |
| EBITDA | $718.60 M | $1.21 B | $1.16 B | $1.01 B | $766.10 M | $1.42 B |
| Interest Expense | -$8.70 M | -$3.60 M | -$19.30 M | -$12.20 M | -$12.90 M | -$11.00 M |
| Depreciation | $126.90 M | $135.10 M | $136.70 M | $145.00 M | $123.20 M | $123.70 M |
| Income Before Tax | $905.00 M | $1.52 B | $1.76 B | $1.04 B | $831.20 M | $1.53 B |
| Income Tax Expense | $96.30 M | $127.10 M | $303.30 M | $199.10 M | $104.00 M | $230.90 M |
| Net Income + | $808.70 M | $1.39 B | $1.46 B | $844.60 M | $727.20 M | $1.30 B |
| Net Profit Margin | 26.7% | 37.86% | 38.89% | 21.74% | 20.17% | 30.23% |
Regeneron Pharmaceuticals Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $100.00 K | $100.00 K | $100.00 K | $100.00 K | $100.00 K | $100.00 K |
| Reserve & Surplus | $32.41 B | $33.73 B | $35.11 B | $35.87 B | $36.44 B | $37.59 B |
| Non-Current Liabilities | $4.59 B | $4.61 B | $4.79 B | $4.93 B | $4.34 B | $4.49 B |
| Current Liabilities | $3.57 B | $3.67 B | $4.43 B | $4.37 B | $5.11 B | $5.53 B |
| Total Liabilities | $8.16 B | $8.28 B | $9.21 B | $9.30 B | $9.45 B | $10.02 B |
| Fixed Assets | $5.86 B | $6.19 B | $6.38 B | $6.38 B | $6.55 B | $6.77 B |
| Current Assets | $17.57 B | $16.86 B | $17.98 B | $18.02 B | $18.21 B | $18.45 B |
| Total Assets | $37.55 B | $38.22 B | $40.17 B | $40.56 B | $40.87 B | $41.73 B |
Regeneron Pharmaceuticals Inc Cash Flow
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $844.60 M | $844.60 M | $727.20 M | $727.20 M | $1.30 B | $1.30 B |
| Operating Cash Flow | $1.17 B | $1.17 B | $1.08 B | $1.08 B | $813.00 M | $813.00 M |
| Investing Cash Flow | $220.30 M | $220.30 M | -$428.90 M | -$428.90 M | -$92.70 M | -$92.70 M |
| Financing Cash Flow | -$780.10 M | -$780.10 M | -$802.20 M | -$802.20 M | -$1.22 B | -$1.22 B |
| Change in Cash | $610.60 M | $610.60 M | -$153.10 M | -$153.10 M | -$504.60 M | -$504.60 M |
Regeneron Pharmaceuticals Inc Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $156.51B | -37.02% | 36.32 | 12.48% | 6.26% |
 | $130.09B | 174.21% | 29.86 | 32.94% | 0.00% |
 | $58.14B | -63.24% | 0.00 | -145.16% | 0.00% |
 | $1.01T | 400.84% | 38.19 | 31.67% | 0.61% |
 | $203.47B | 73.12% | 23.37 | 20.98% | 2.68% |
 | $1.61B | -92.21% | 0.00 | -609.85% | 0.00% |
 | $183.12B | 110.71% | 0.00 | 28.90% | 2.22% |
 | $357.52B | 105.29% | 115.74 | 28.09% | 2.35% |
 | $1.78B | -79.98% | 0.00 | -638.87% | 0.00% |
 | $463.89B | 145.08% | 74.25 | 6.92% | 2.64% |
Regeneron Pharmaceuticals Inc Return Calculator
The Regeneron Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$11,673
Invested Amount$10,000
Est. Returns$1,673
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Popular Stocks
FAQs
What is the share price of Regeneron Pharmaceuticals Inc today?
Regeneron Pharmaceuticals Inc (REGN) share price as of September 18, 2026 is $760.91. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Regeneron Pharmaceuticals Inc?
Yes, Indian Investors can invest in the Regeneron Pharmaceuticals Inc (REGN) Share by opening an international trading account with Angel One.
How can I purchase Regeneron Pharmaceuticals Inc shares in India?
Purchasing Regeneron Pharmaceuticals Inc (REGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Regeneron Pharmaceuticals Inc (REGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Regeneron Pharmaceuticals Inc?
Yes, you can purchase fractional shares of Regeneron Pharmaceuticals Inc (REGN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Regeneron Pharmaceuticals Inc?
The market capitalization of Regeneron Pharmaceuticals Inc on September 18, 2026, is $79.75 B.
In which sector Regeneron Pharmaceuticals Inc belongs?
Regeneron Pharmaceuticals Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Regeneron Pharmaceuticals Inc stocks?
In order to invest in Regeneron Pharmaceuticals Inc (REGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
